Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis-Reference-Cited by-同舟云学术

Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis

Published:2019-01 Issue:1 Volume:18 Page:107-116
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Mole Sara E,Anderson Glenn,Band Heather A,Berkovic Samuel F,Cooper Jonathan D,Kleine Holthaus Sophia-Martha,McKay Tristan R,Medina Diego L,Rahim Ahad A,Schulz Angela,Smith Alexander J

Funder

Horizon 2020 Framework Programme

Medical Research Council

Batten Disease Family Association

University College London

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference86 articles.

1. NCL diseases-clinical perspectives;Schulz;Biochim Biophys Acta,2013

2. Human NCL neuropathology;Radke;Biochim Biophys Acta,2015

3. Genetics of the neuronal ceroid lipofuscinoses (Batten disease);Mole;Biochim Biophys Acta,2015

4. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses;Williams;Neurology,2012

5. The neuronal ceroid lipofuscinoses: opportunities from model systems;Faller;Biochim Biophys Acta,2015

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease;Ophthalmology Science;2024-11

2. TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells;Scientific Reports;2024-07-29

3. Early Symptoms and Treatment Outcomes in Neuronal Ceroid Lipofuscinosis Type 2: Croatian Experience;Journal of Personalized Medicine;2024-07-24

4. Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood‐brain barrier;Exploration;2024-07-09

5. Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis in Patients and a Murine Model;Annals of Neurology;2024-06-15